Immunovant Inc. Common Stock vs Powell Industries — how do they compare? Immunovant Inc. Common Stock trades at $30.38 (market cap $6.25B), while Powell Industries trades at $191.83 (market cap $6.89B). The key difference: Immunovant Inc. Common Stock and Powell Industries are close in size by market cap, and Powell Industries pays a 0.19% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Powell Industries for 4 Days on average.
| IMVT | POWL | |
|---|---|---|
Market Cap | $6.25B | $6.89B |
Volume | 1,755,411 | 728,725 |
Sector | Health | Industrials |
52-Week High | $44.96 | $322.05 |
52-Week Low | $17.03 | $94.02 |
Typical Hold Time | 0 Days | 4 Days |
Enterprise Value | $5.35B | $6.26B |
Dividend Yield | — | 0.19% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →Powell Industries designs and manufactures electrical equipment and engineered solutions for power distribution and control. Its products are used across energy, utility, industrial, and commercial infrastructure.
Read more on POWL →